CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

EGFR exon 19 deletion

Gene: EGFR · Type: mutation

Indications: Non-small cell lung cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
OsimertinibNon-small cell lung cancerINDICATED
FDA Label
Label
ErlotinibNon-small cell lung cancerINDICATED
FDA Label
Label
GefitinibNon-small cell lung cancerINDICATED
FDA Label
Label
AfatinibNon-small cell lung cancerINDICATED
FDA Label
Label